Acta Chir Orthop Traumatol Cech. 2018; 85(3):179-185 | DOI: 10.55095/achot2018/029

Two-Stage Revision for Periprosthetic Infection of the Total Hip Arthroplasty: a Comparison of Two MethodsOriginal papers

J. VČELÁK1,*, M. MACKO1, R. KUBEŠ1, K. NĚMEC1, M. FRYDRYCHOVÁ2
1 Ortopedická klinika 1. lékařské fakulty Univerzity Karlovy a Institut postgraduálního vzdělávání ve zdravotnictví, Nemocnice Na Bulovce, Praha
2 Ortopedické oddělení Krajská zdravotní, a. s., Masarykova nemocnice Ústí nad Labem, o.z.

PURPOSE OF THE STUDY:
The purpose of the study is a retrospective comparison of results of the two-stage revision total hip arthroplasty using a non-articulating and an articulating spacer to treat periprosthetic joint infection (PJI). Two basic hypotheses are evaluated: (1) the clinical outcomes of the patients treated with "hand made" articulating cement spacer are better than in non-articulating patient's group in two-stage revision for PJI of the total hip arthroplasty and (2) PJI recurrence is higher in the group of patients treated with an articulating spacer group.

MATERIAL AND METHODS:
The evaluated group consists of a total of 57 patients (23 women, 34 men) with the mean age of 61.2 years. Group A of 39 patients were treated by two-stage revision using the "hand-made" articulating cement spacer and Group B of 18 patients were treated using the non-articulating spacer. Both the groups were evaluated retrospectively in the reference period: pre-operatively and two years after the surgery using the Harris Hip Score (HHS) clinical assessment. The revision surgery for acute and chronic complications of treatment, length of hospitalization, and the PJI recurrence were evaluated for both the groups.

RESULTS:
The resulting HHS clinical reviews were pre-operatively 43.59 points in both the groups with postoperative improvement up to 81.74 points. The mean preoperative HHS scores were 41.67 points (Group A) and 47.77 points (Group B) and two years after the surgery they were 83.43 points (Group A) and 78.08 points (Group B) (two-tailed t-test, p-value = 0.042). In Group A a total of seven revisions were performed in the interval between the two-stage revision (4x recurrent dislocation, 2x persistent infection, 1x spacer fracture). In Group B one patient was revised for persistent infection. In the two-year period after the operation, a relapse of PJI was recorded in 5 patients in Group A (12.8%) and in 1 patient in Group B (5.6%) (Chi-square test, p-value = 0.41). The average time of hospitalization was 51.58 days, whereby 49.72 days and 55.61 days on average for Group A and B respectively (p-value = 0.53).

DISCUSSION:
According to recent studies, the advantage of motion preservation in articulating cement spacers can be complicated by recurrent dislocations, implant migration, periprosthetic fractures or recurrent joint replacement infections, which can further prolong the treatment and worsen the final clinical results. An alternative treatment option is the application of a non-articulating spacer maintaining the advantage of local administration of antibiotics and reducing the dead space formed by the infected implant removal. Discussed is mainly the choice of the method in case of muscle disorder or presence of segmental bone defects.

CONCLUSIONS:
The results demonstrate the better clinical outcomes and the higher revision rate of patients with an articulating cement spacer in two stage revision. We didn't find any differences between the risk of PJI recurrence in both groups.

Keywords: periprosthetic infection, total hip replacement, cement spacer, two stage revision, articulating spacer, non-articulating spacer

Published: June 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
VČELÁK J, MACKO M, KUBEŠ R, NĚMEC K, FRYDRYCHOVÁ M. Two-Stage Revision for Periprosthetic Infection of the Total Hip Arthroplasty: a Comparison of Two Methods. Acta Chir Orthop Traumatol Cech. 2018;85(3):179-185. doi: 10.55095/achot2018/029. PubMed PMID: 30257776.
Download citation

References

  1. Andersen PK, Geskus RB, de Witte T, Putter H. Competing risks in epidemiology: possibilities and pitfalls. Int J Epidemiol. 2012;41:861-870. Go to original source... Go to PubMed...
  2. Artiaco S, Boggio F, Colzani G, Titolo P, Zoccola K, Bianchi P, Bellomo F. Megaprostheses in the revision of infected total hip arthroplasty: clinical series and literature review. Bull Hosp Dis. 2015;73:229-232.
  3. Ballay R, Landor I, Růžička F, Melicherčík P, Tomaides J, Jahoda D. Aloplastické materiály s pohledu jejich citlivosti ke kolonizaci bakteriemi. Acta Chir Orthop Traumatol Cech. 2016;83:163-168. Go to original source... Go to PubMed...
  4. Berend KR, Lombardi AV, Morris MJ, Bergeson AG, Adams JB, Sneller MA. Two-stage treatment of hip periprosthetic joint infection is associated with a high rate of infection control but high mortality. Clin Orthop Relat Res. 2013;471:510-518. Go to original source... Go to PubMed...
  5. Bjerke-Kroll BT, Christ AB, McLawhorn AS, Sculco PK, Jules-Elysée KM, Sculco TP. Periprosthetic joint infections treated with two-stage revision over 14 years: an evolving microbiology profile. J Arthroplasty. 2014;29:877-882. Go to original source... Go to PubMed...
  6. Cierny G, Mader JT, Penick HA. Clinical staging system of adult osteomyelitis. Contemp Orthop. 1985;10:17-37.
  7. Cooper HJ, Della Valle CJ. The two-stage standard in revision total hip replacement. Bone Joint J. 2013;95-B(Suppl A):84-87. Go to original source... Go to PubMed...
  8. Fink B, Rechtenbach A, Buchner H, Vogt S, Hahn M. Articulating spacers used in two-stage revision of infected hip and knee prostheses abrade with time. Clin Orthop Relat Res. 2011;469: 1095-1102. Go to original source... Go to PubMed...
  9. Fink B, Vogt S, Reinsch M, Buchner H. Sufficient release of antibiotic by a spacer 6 weeks after implantation in two-stage revision of infected hip prostheses. Clin Orthop Relat Res. 2011;469:3141-3147. Go to original source... Go to PubMed...
  10. Gallo J, Smižanský M, Radová L, Potomková J. Porovnání léčebných postupů používaných v terapii infekce kloubních náhrad kyčle a kolena. Acta Chir Orthop Traumatol Cech. 2009;76:302-309. Go to original source... Go to PubMed...
  11. Hoberg M, Konrads C, Engelien J, Oschmann D, Holder M, Walcher M, Steinert A, Rudert M. Similar outcomes between two-stage revisions for infection and aseptic hip revisions. Int Orthop (SICOT). 2016;40:459-464. Go to original source... Go to PubMed...
  12. Ilchmann T, Zimmerli W, Ochsner PE, Kessler B, Zwicky L, Graber P, Clauss M. One-stage revision of infected hip arthroplasty:outcome of 39 consecutive hips. Int Orthop (SICOT). 2016;40:913-918. Go to original source... Go to PubMed...
  13. Jiranek WA, Waligora AC, Hess SR, Golladay GL. Surgical treatment of prosthetic joint infections of the hip and knee: changing paradigms? J Arthroplasty. 2015;30:912-918. Go to original source... Go to PubMed...
  14. Lange J, Troelsen A, Soballe K. Chronic periprosthetic hip joint infection. a retrospective, observational study on the treatment strategy and prognosis in 130 non-selected patients. PLoS ONE. 2016;11:e0163457. Go to original source... Go to PubMed...
  15. Lee W, Hwang D, Kang C, Shin B, Zheng L. Usefulness of prosthesis made of antibiotic-loaded acrylic cement as an alternative implant in older patients with medical problems and periprosthetic hip infection: a 2- to 10-year follow-up study. J Arthroplasty. 2017;32:228-233. Go to original source... Go to PubMed...
  16. McPherson EJ, Woodson C, Holtom P, Roidis N, Shufelt C, Patzakis M. Periprosthetic total hip infection: outcomes using a staging system. Clin Orthop Relat Res. 2002;403:8-15. Go to original source...
  17. Neumann DR, Hofstaedter T, List C, Dorn U. Two-stage cementless revision of late total hip arthroplasty infection using a pre manufactured spacer. J Arthroplasty. 2012;27:1397-1401. Go to original source... Go to PubMed...
  18. Parvizi J, Zmistowski B, Berbari EF, Bauer TW, Springer BD, Della Valle CJ, Garvin KL, Mont MA, Wongworawat, MD, Zalavras CG. New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society. Clin Orthop Relat Res. 2011;469:2992-2994. Go to original source... Go to PubMed...
  19. Pignatti G, Nitta S, Rani N, Dallari D, Sabbioni G, Stagni C, Giunti A. Two stage revision in periprosthetic infection: results of 41 cases. The Open Orthop J. 2010;4:193-200. Go to original source... Go to PubMed...
  20. Shanmugasundaram S, Ricciardi BF, Briggs TW, Sssmann PS, Bostrom MP. Evaluation and management of periprosthetic joint infection-an international, multicenter study. HSSJ. 2014;10:36-44. Go to original source... Go to PubMed...
  21. Singh G, Deutloff N, Maertens N, Meyer H, Awiszus F, Feuerstein B, Roessner A, Lohmann CH. Articulating polymethylmethacrylate (PMMA) spacers may have an immunomodulating effect on synovial tissue. Bone Joint J. 2016;98-B:1062-1068. Go to original source... Go to PubMed...
  22. Spiegl U, Friederichs J, Patzold R, Militz M, Josten Ch, Buren V. Risk factors for failed two-stage procedure after chronic post traumatic periprosthetic hip infections. Arch Orthop Trauma Surg. 2013;133:421-428. Go to original source... Go to PubMed...
  23. Strange S, Whitehouse MR, Beswick AD, Board T, Burston A, Burston B, Carroll FE, Dieppe P, Garfield K, Gooberman-Hill R, Jones S, Kunutsor S, Lane A, Lenguerrand E, MacGowan A, Moore A, Noble S, Simon J, Stockley I, Taylor AH, Toms A, Webb J, Whittaker JP, Wilson M, Wylde V, Blom AW. One-stage or two-stage revision surgery for prosthetic hip joint infection - the INFORM trial: a study protocol for a randomised controlled trial. Trials. 2016;17:90. Go to original source... Go to PubMed...
  24. Tikhilov R, Bozhkova S, Denisov A, Labutin D, Shubnyakov I, Razorenov V, Artyukh, Klitsenko O. Risk factors and a prognostic model of hip periprosthetic infection recurrence after surgical treatment using articulating and non-articulating spacers. Int Orthop (SICOT). 2016;40:1381-1387. Go to original source... Go to PubMed...
  25. Toulson C, Walcott-Sapp S, Hur J, Salvati EA, Bostrom M, Brause BD, Westrich GH. Treatment of infected total hip arthroplasty with a 2-stage reimplantation protocol. J Arthroplasty. 2009;24:1051-1060. Go to original source... Go to PubMed...
  26. Triantafyllopoulos GK, Memtsoudis SG, Zhang W, Ma Y, Sculco TP, Poultsides LA. periprosthetic infection recurrence after 2-stage exchange arthroplasty: failure or fate? J Arthroplasty. [Epub 2016] 2017;32:526-531. Go to original source... Go to PubMed...
  27. Tsukayama DT, Estrada R, Gustilo RB. Infection after total hip arthroplasty. A study of one hundred and six infections. J Bone Joint Surg Am. 1996;78:512-523. Go to original source... Go to PubMed...
  28. Uchiyama K, Takaira N, Fukushima K, Moriya M, Yamamoto T, Minegishi Y, Sakai R, Itoman M, Takaso M. Two-stage revision total hip arthroplasty for periprosthetic infections using antibiotic-impregnated cement spacers of various types and materials. ScientificWorldJournal. 2013;2013:147248. Go to original source... Go to PubMed...
  29. Zeller V, Lhotellier L, Marmor S, Leclerc P, Krain A, Graff W., Ducroquet F, Biau D, Leonard P, Desplaces N, Mamoudy P. One-stage exchange arthroplasty for chronic periprosthetic hip infection: results of a large prospective cohort study. J Bone Joint Surg Am. 2014;96:e1. Go to original source... Go to PubMed...